SCHEMBL7604273

SCHEMBL7604273

Cn1c(=O)n(COCc2ccccc2)c(=O)c2[nH]cnc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 6/20 0.72
▸ ADORA3 P0DMS8 5/20 0.72
▸ PDE4A P27815 6/20 0.59
▸ PDE4B Q07343 6/20 0.59
▸ PDE4C Q08493 6/20 0.59
▸ PDE4D Q08499 6/20 0.59
▸ ADORA2A P29274 4/20 0.59
▸ CFTR P13569 1/20 0.55
▸ KMT2A Q03164 2/20 0.54
▸ MAPK1 P28482 1/20 0.52
▸ ATAD2 Q6PL18 1/20 0.51
▸ PIK3CD O00329 1/20 0.50
▸ ALPL P05186 1/20 0.50
▸ TMIGD3 P0DMS9 1/20 0.50
▸ ADORA1 P30542 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ POLB P06746 2/20 0.49
▸ CHIT1 Q13231 1/20 0.49
▸ CHIA Q9BZP6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7453870 0.84 ADORA2B (1.00) ADORA2BADORA3PDE4APDE4BPDE4C
SCHEMBL31061426 0.83 ADORA2B (1.00) ADORA2BADORA3PDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL8656191 0.83 ADORA2B (0.97) ADORA2BADORA3PDE4APDE4BPDE4C
SCHEMBL7455363 0.82 ADORA2A (0.72) ADORA2BADORA3PDE4APDE4BPDE4C
SCHEMBL3116806 0.81 ADORA2B (1.00) ADORA2BADORA3PDE4APDE4BPDE4C
SCHEMBL7608745 0.79 ADORA2B (0.71) ADORA2BADORA3PDE4APDE4BPDE4C
SCHEMBL7605748 0.79 ADORA2B (0.63) ADORA2BADORA3PDE4APDE4BPDE4C
SCHEMBL7607714 0.79 CFTR (0.70) ADORA2BADORA3PDE4APDE4BPDE4C
SCHEMBL7606755 0.78 ADORA2B (0.58) ADORA2BADORA3PDE4APDE4BPDE4C
SCHEMBL7603135 0.78 ADORA2B (0.70) ADORA2BADORA3PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 — — US claimed
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 — — EP disclosed
CN-1066146-C Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof AVENTIS PHARMACEUTICALS AG (DE) 2001-05-23 — — CN disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 — — US disclosed
CN-1169993-A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof HOECHST AG (DE) 1998-01-14 — — CN disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 — — EP disclosed
Send feedback